Korro Bio Inc. (NASDAQ: KRRO)
$49.34
-3.0100 ( -5.75% ) 21.4K
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Market Data
Open
$49.34
Previous close
$52.35
Volume
21.4K
Market cap
$461.33M
Day range
$47.33 - $52.24
52 week range
$14.00 - $97.91
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 68 | May 14, 2024 |
8-k | 8K-related | 13 | May 14, 2024 |
3 | Insider transactions | 2 | May 14, 2024 |
def | Proxies and info statements | 4 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
4 | Insider transactions | 2 | Apr 24, 2024 |
4 | Insider transactions | 2 | Apr 24, 2024 |
4 | Insider transactions | 2 | Apr 24, 2024 |
4 | Insider transactions | 2 | Apr 24, 2024 |
4 | Insider transactions | 2 | Apr 24, 2024 |